24.07 -1.32 (-5.19%)
PRX
Stock Details
Last Trade:24.07 Change:-1.32 (-5.19%) Prev Close:25.39 Open: 25.41 Days Range:23.09 – 25.52 52 Week Range: 8.57 - 27.93 Volume:1919963 P/E: 23.14EPS:1.04
View AllRecent Alerts 02/09/10
Recent Alert on 02/08/10 at 7:04am
Par Pharma (PRX) Subsidiary Strativa Receives Response Letter from U.S. FDA for Zuplenz
Par Pharma (PRX) Subsidiary Strativa Receives Response Letter from U.S. FDA for Zuplenz
Strativa Pharmaceuticals, a Par Pharmaceutical (NYSE: PRX) subsidiary, announced today that the U.S. Food and Drug Administration (FDA) issued a complete response letter regarding the new drug application (NDA) for Zuplenz® (ondansetron) oral... Read More
Recent Alert on 02/08/10 at 7:04am
Par Pharma (PRX) Subsidiary Strativa Receives Response Letter from U.S. FDA for Zuplenz
Par Pharma (PRX) Subsidiary Strativa Receives Response Letter from U.S. FDA for Zuplenz
Recent Alert on 02/02/10 at 2:00pm
Unusual 11 Mid-Day Movers 2/2: CITP, BSDM, RTEC, NOA, FSII Higher; FBP, DST, GU, SNTS Lower
Unusual 11 Mid-Day Movers 2/2: CITP, BSDM, RTEC, NOA, FSII Higher; FBP, DST, GU, SNTS Lower
Recent Alert on 11/16/09 at 8:31am
Par Pharma (PRX) Receives Final U.S. FDA Approval for Tramadol ER Doses
Par Pharma (PRX) Receives Final U.S. FDA Approval for Tramadol ER Doses
Recent Alert on 11/16/09 at 8:31am
Par Pharma (PRX) Receives Final U.S. FDA Approval for Tramadol ER Doses
Par Pharma (PRX) Receives Final U.S. FDA Approval for Tramadol ER Doses
View AllRecent Press Releases
Press Release on 02/05/10 at 4:45pm
Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
Strativa Pharmaceuticals Provides An Update On Zuplenz(R) (Ondansetron) Oral Soluble Film
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/19/09 at 1:05pm
Analyst upgrades, downgrades and initiations: AXP, HAL, EL, MAT, CAT....
Analyst upgrades, downgrades and initiations: AXP, HAL, EL, MAT, CAT....